Canadian Observational Study Evaluating the Long-term IMPACT of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators on People With CF
Canadian Observational Study Evaluating the Long-term IMPACT of CFTR (Can-IMPACT CF)
University of British Columbia
500 participants
Nov 1, 2021
OBSERVATIONAL
Conditions
Summary
This observational study intends to investigate health trends and data in cystic fibrosis patients all across Canada that are receiving modulator treatment so researchers can determine if CFTR treatments are effective over a long period of time and if so, which treatments work best for each individual. The study will collect clinical data from routine standard of care, patient reported outcomes via survey data and samples for a biobank.
Eligibility
Inclusion Criteria3
- Prescribed a CFTR modulator therapy and planning to commence modulator therapy within 30 days OR planning to switch modulator therapies within 30 days
- Participates in the Canadian Cystic Fibrosis Registry (CCFR)
- Informed consent by participant, or parent/legal guardian or assent
Exclusion Criteria1
- Known contraindications to CFTR modulator therapy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Highly Effective CFTR Modulator Therapy
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05200429